Vascular Response to Brachytherapy Using Functional OCT
NCT01955941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49
Last updated 2023-06-26
Summary
The purpose of this study is to learn how blood flows to tumors in patients treated with I-125 plaque brachytherapy for uveal melanoma.
Conditions
Sponsors & Collaborators
-
OHSU Knight Cancer Institute
lead OTHER
Principal Investigators
-
Alison Skalet, MD, PhD · OHSU Knight Cancer Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2021-11-22
- Completion
- 2021-11-22
Countries
- United States
Study Locations
More Related Trials
-
Coagulation System In STereotactic Radiotherapy Of NSCLC
NCT03893461 ·Status: UNKNOWN
-
Dose-painting Radiation for LA-NSCLC
NCT05031533 ·Status: RECRUITING ·Phase: NA
-
Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.
NCT03931356 ·Status: COMPLETED
-
Functional Imaging of Treatment Effects: A Companion Protocol to a Study of Extracranial Stereotactic Radioablation in Early Stage Non-Small Cell Lung Cancer
NCT00246116 ·Status: COMPLETED ·Phase: NA
-
19F Thoracic Radiotherapy for Lung Cancer
NCT03315065 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Optical Coherence Tomography in Patients With Radiotherapy for Head and Neck Cancer
NCT04610645 ·Status: COMPLETED
-
Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma
NCT04744935 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy
NCT06870942 ·Status: RECRUITING ·Phase: PHASE2
-
Electronic Brachytherapy for the Treatment of NMSC
NCT01016899 ·Status: COMPLETED
-
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
NCT05599048 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Hyperpolarized Xenon Gas MR Imaging in NSCLC Radiotherapy
NCT02151604 ·Status: COMPLETED ·Phase: PHASE2
-
FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax
NCT05524064 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
NCT03035890 ·Status: COMPLETED ·Phase: NA
-
Radiotherapy Safety for Liver Malignancies Using Post-Treatment Imaging
NCT07346573 ·Status: COMPLETED
-
Palliative UNConventional Hypofractionation Trial for Metastatic Bone Disease
NCT05115331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Stereotactic Body Radiation Therapy (SBRT) Efficiency and Toxicity in Liver Cancer
NCT03408665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer
NCT05150145 ·Status: RECRUITING ·Phase: NA
-
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases
NCT02159742 ·Status: ACTIVE_NOT_RECRUITING
-
Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal Carcinoma
NCT06244394 ·Status: COMPLETED
-
Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer
NCT02228356 ·Status: UNKNOWN
-
A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)
NCT05903430 ·Status: RECRUITING
-
MR-informed Stereotactic Radiotherapy for Treatment of Ultracentral Lung Tumours Utilising a Dedicated MR-simulator for Daily Adaptation Followed by CBCT-guided Treatment Delivery
NCT06815289 ·Status: RECRUITING ·Phase: NA
-
Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients
NCT01859650 ·Status: COMPLETED
-
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
NCT06159660 ·Status: RECRUITING
-
Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy
NCT01777802 ·Status: COMPLETED